LTFS
GNCA

Ladenburg Thalmann Financial Services’s Genocea Biosciences, Inc. GNCA Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-38
Closed – – 5286
2017
Q4 		$0 Hold
38
– – ﹤0.01% 5199
2017
Q3 		$0 Hold
38
– – ﹤0.01% 5107
2017
Q2 		$2K Hold
38
– – ﹤0.01% 4666
2017
Q1 		$2K Hold
38
– – ﹤0.01% 4635
2016
Q4 		$1K Hold
38
– – ﹤0.01% 4773
2016
Q3 		$2K Hold
38
– – ﹤0.01% 4550
2016
Q2 		$1K Hold
38
– – ﹤0.01% 4670
2016
Q1 		$2K Hold
38
– – ﹤0.01% 4438
2015
Q4 		$2K Buy
+38
New +$1.81K ﹤0.01% 4417

Other funds holding GNCA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ladenburg Thalmann Financial Services's GNCA Position: Q1 2018 in Review

Ladenburg Thalmann Financial Services sold out of Genocea Biosciences, Inc. (GNCA) in Q1 2018, closing a stake of 38 shares.

Ladenburg Thalmann Financial Services first reported a position in GNCA in Q4 2015 and held it in 9 quarters. The position peaked at $2K in Q2 2017. 65 funds tracked by Wall St. Rank hold GNCA as of Q1 2018.

  • Ladenburg Thalmann Financial Services reported no remaining Genocea Biosciences, Inc. position as of Q1 2018 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 38 Genocea Biosciences, Inc. shares in Q1 2018.
  • Ladenburg Thalmann Financial Services first reported a position in Genocea Biosciences, Inc. in Q4 2015 and held it in 9 quarters.
  • Ladenburg Thalmann Financial Services's Genocea Biosciences, Inc. position peaked at $2K in Q2 2017.
  • 65 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q1 2018.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q1 2018, filed 15 May 2018.